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Abstract
Background: N-ethyl-N-nitrosourea (ENU)-induced mutagenesis is a powerful tool for the study of gene function and the
generation of human disease models. A large number of mouse mutants obtained by ENU-induced mutagenesis with a
variety of phenotypes have been recovered. However, after genetic confirmation testing, only approximately 50% of the
abnormal phenotypes were found to be heritable.
Methodology/Principal Findings: A mouse mutant, Dp1, with a dilated pupil phenotype was induced with an N-ethyl-N-
nitrosourea (ENU) mutagenesis strategy. Sequence analysis for Nrg1 reveals a G.A base substitution that flanks exon E59,
encoding for an EGFb domain, in the 59 splice donor site. The mutation affects but does not abolish the splicing of EGFb-
type Nrg1 mRNA in Dp1 mice and produces several different transcripts by activating other, cryptic splice sites. These types
of protein isoforms are expected, and the result shows that, in the mutant, the effect is a decrease in but not an elimination
of the high affinity EGFb-type Nrg1 isoforms. This is partially compensated for by an increase in expression of the low affinity
alpha forms or inactive proteins, suggesting that the mutation results in a hypomorphic allele. Interestingly, genetic model
testing shows that Dp1 is a mutation that results in a dilated pupil phenotype that is inherited with very low penetrance
when heterozygous and with complete penetrance when homozygous. Pharmacological and immunohistochemical tests
show a reduction of muscarinic (M) receptors in the sphincter pupillae of Dp1 mice, which is a major cause of dilated pupils.
Conclusions/Significance: This study is the first report of an Nrg1 mutation being associated with a dilated pupil phenotype
and the reduction of M receptors. This report may help in establishing more mutant mouse lines and models of human
genetic disease and can be applied to other organisms. Dp1 mice are a valuable resource for the further clarification of Nrg1
biological function.
Citation: Chen B, Li K, Zhang F, Zhai G, Gong W, et al. (2011) An ENU-Induced Mutation of Nrg1 Causes Dilated Pupils and a Reduction in Muscarinic Receptors in
the Sphincter Pupillae. PLoS ONE 6(9): e25176. doi:10.1371/journal.pone.0025176
Editor: Jennifer V. Schmidt, University of Illinois at Chicago, United States of America
Received March 30, 2011; Accepted August 29, 2011; Published September 19, 2011
Copyright:  2011 Chen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the National Natural Science Fund of China (31000987 and 30670299). The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: xuezfyz@yahoo.com.cn
Introduction
N-ethyl-N-nitrosourea (ENU) is a powerful point mutagen that
can generate random mutations in the mouse genome [1–3].
Following an ENU-mutagenesis screen for dominant and recessive
mutations, a large number of mouse mutants with a variety of
phenotypes were recovered. After genetic confirmation testing,
approximately 50% of the abnormal phenotypes were found to be
heritable, but the rest were not (including mice that failed to breed
due to illness or fertility problems and those that died before genetic
confirmationtesting)[4,5].Onepossibleexplanationforthisresultis
that some of the abnormal phenotypes, which were not previously
considered to be inheritable, are multigenic traits, rather than
monogenic. Another cause could be environmental factors.
However, we cannot exclude the possibility that some abnormal
phenotypes, which were not previously considered to be inheritable,
are heritable with a very low penetrance in the heterozygous state.
The neuregulins are a family of four genes (Nrg1–4), encoding
for proteins that mediate cell-cell interactions in the brain and
other organs by signaling through ErbB receptor tyrosine kinases.
Neuregulin 1 (NRG1) is the most well characterized member of
the family, and Nrg1 is also a leading schizophrenia susceptibility
gene [6–11]. Over 15 different NRG1 isoforms are produced from
the single Nrg1 gene. All isoforms contain a core EGF domain,
EGFc, encoded by exon E130, but other elements of the protein
are variable. There are several sources of this variation including:
1) Distinct promoter usage results in different ‘‘types’’ of NRG1 as
defined by their 59 exon. Currently, six types of NRG1 have been
reported (types I–VI) in humans and three types (types I–III) in
mice. Types I, II, IV, and V NRG1s are sometimes referred to as
‘‘Ig-NRG1’’, and type III NRG1s are sometimes referred to as
‘‘CRD-NRG1’’. 2) Retention of exon E68 or E59 results in the
inclusion of EGFa or b variants, respectively. NRG1s with a b-
type EGF sequence are predominant in the brain. 3) Most NRG1
isoforms have a transmembrane domain (TMc; exon E103)
preceded by a ‘‘1’’ stalk (exon E24; TMc-containing NRG1s
without a stalk are known as ‘‘2’’ isoforms); Isoforms with a ‘‘3’’
stalk (exon E551 in human) are truncated at that point, lack the
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carboxy tail can be either the ‘‘a’’ or ‘‘b’’ form [12–14].
TheDp1-Cmcyz(Dilatedpupilmutation1,ComparativeMedicine
Center, Yangzhou University, hereafter Dp1) mutant was identified
as a new ENU-induced mutant with a dilated pupil phenotype.
Here,wereportthat theabnormalphenotypeisdue toa mutationin
the Nrg1 gene, which causes a reduction in muscarinic receptors in
the sphincter papillae.Interestingly, the Dp1 dilated pupilphenotype
is inherited with very low penetrance in heterozygous mice and with
complete penetrance in homozygous mice.
Results
The dilated pupil phenotype in Dp1 mice
Dp1 is an ENU-induced mutation conveying either a unilateral
or bilaterally dilated pupil phenotype that can range from partial
to severe (Figure 1). When illuminated, the eyes of affected Dp1
mice have no pupillary response to light, and the sphincter
pupillae fail to act.
The founder Dp1 male mouse, which was the progeny of an
ENU-treated B6 male mouse and an untreated B6 female mouse,
had a unilateral dilated pupil phenotype. After mating the mutant
with B6 mice, a very low percentage of the progeny (3/115) were
recorded to have the unilateral dilated pupil phenotype.
Interestingly, crosses among the three heterozygous progeny
resulted in five out of 34 abnormal progeny, of which four had
bilaterally dilated pupils. All progeny generated by crossing the
above four bilaterally dilated pupil individuals with each other had
a dilated pupil phenotype.
The Dp1 dilated pupil phenotype is caused by a mutation
in the Nrg1 gene
For initial mapping, we tested genomic DNA from 25N2 samples
with microsatellite markers across the whole genome. We observed
no exchange of the markers D8Mit171 and D8Mit4 with the dilated
pupil phenotype and found no significant linkages with other
chromosomal loci. In order to further refine the map position, we
crossbred F1 mice and reduced the critical interval to a 1.52-Mb
region between the single nucleotide polymorphism (SNP)
rs32829041 and D8Mit4 using 118 F2, dilated pupil offspring
(Figure 2). The region contained 7 protein coding genes (Dusp26,
Rnf122, BC019943, Mak16, Fut10, 7420700N18Rik, and Nrg1), 1
miRNA gene (Mir1186) and 1 snoRNA gene (Snord13). Sequence
analysis of the exons and flanking intronic sequences using DNA or
mRNA of these genes revealed no apparent nucleotide changes in
Dp1 mice except for Neuregulin-1 (Nrg1).
In the Nrg1 gene, we discovered a G.A transition mutation,
which flanked exon E59, encoding for the EGFb domain, in the 59
splice donor site (Figure 3A–C). In order to assess the effect of the
G.A substitution on EGFb-type Nrg1 mRNA splicing, we
amplified the sequences from RNA harvested from the brains of
mice homozygous for the Nrg1 mutation and wild-type B6 mice
using primers specific for CRD-Nrg1 and Ig-Nrg1, respectively. For
both CRD-Nrg1 and Ig-Nrg1 RT-PCR products, electrophoresis
results revealed three bands from both Dp1 and wild-type B6 mice
(Figure 3D). The middle band (band b), corresponding to NRG1s
with a b1-type EGF sequence (see below), was predominant in the
brain of wild-type B6 mice. Quantitative analysis by densitometry
shows that, in homozygous mice, the relative yield of band b in
CRD-Nrg1 and Ig-Nrg1 is only 42.6% and 32.8%, respectively, of
that in wild-type B6 mice (Figure 3E).
To determine the sequences amplified by RT-PCR analysis,
individual bands generated from both wild-type and Dp1 mice
were purified and used directly as templates for nucleotide
sequencing. Sequence analysis of the middle band of CRD-Nrg1
and Ig-Nrg1 from wild-type mice revealed wild-type sequences
corresponding to CRD-b1 and Ig-b1 Nrg1 (Figure 4B: band b;
Figure 5B: band b). However, sequence analysis of the middle
band of CRD-Nrg1 and Ig-Nrg1 in Dp1/Dp1 mice revealed a mixed
sequence (data not shown). Sequence analysis of the lowest band
(band c) from both wild-type and Dp1/Dp1 mice revealed
alternative splicing transcripts that lacked exons E59 and E24
when compared to the corresponding band b sequence from wild-
type mice (Figure 4B and C: band c; Figure 5B and C: band c). To
our knowledge, these are new transcripts that have not previously
been reported. Sequence analysis of the top band (band a) of CRD-
Nrg1 and Ig-Nrg1 from wild-type and Dp1/Dp1 mice revealed a
mixed sequence (data not shown). We cloned the bands with
mixed sequences into a T vector and then sequenced the plasmids.
Sequencing of these bands revealed differences in the transcripts
between Dp1/Dp1 and wild-type mice. The majority of the
transcripts found in Dp1/Dp1 bypass the mutated splice donor site
by splicing over exon E59, activating a cryptic splice site, or
transcribing through exon E59 into the adjacent sequence. These
types of protein isoforms were expected, and the results show that,
in the mutant, there is a decrease in, but not an elimination of,
EGFb-type Nrg1 isoforms. This decrease is partially compensated
for by increased expression of the alpha forms, inactive isoforms
(without EGFb, and EGFa domains), and truncated proteins
(without the EGFc, EGFb, and EGFa domains) (Figure 4B and C:
bands a and b; Figure 5B and C: bands a and b).
The dilated pupil phenotype is inherited with very low
penetrance in heterozygous mice and complete
penetrance in homozygous mice
To determine the inheritance pattern of the dilated pupil
phenotype, genetic model testing based on genotyping for a TaiI
Figure 1. Pupil phenotype of Dp1 mice. (A) Wild-type mouse with normal pupil. (B) Dp1 mouse with a partially dilated pupil phenotype
(heterozygous mouse). (C) Dp1 mouse with a severely dilated pupil phenotype (homozygous mouse).
doi:10.1371/journal.pone.0025176.g001
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unaffected Dp1/+ mice with each other, Dp1/Dp1 mice with
unaffected Dp1/+ mice, Dp1/Dp1 mice with wild-type mice, and
Dp1/Dp1 mice with each other. The results show that Dp1 is a
mutation with a dilated pupil phenotype that is inherited with very
low penetrance (5/111) when heterozygous and with complete
penetrance when homozygous (Table 1).
Additionally, in this test, all affected Dp1/+ mice had a
unilateral and partially dilated pupil phenotype that varied in
phenotypic severity, and the vast majority of the Dp1/Dp1 mice
had bilaterally dilated pupils with a severe phenotype (defined as a
complete or nearly completely dilated pupil phenotype). Pan-
NRG1 knockout (KO) mice (mice in which all NRG1 isoforms are
unable to bind to and activate ErbB receptors due to the
disruption of the EGF-like domain) and mice with all Ig-NRG1
isoforms inactivated die at E10.5 [15,16], and mice with all CRD-
NRG1 isoforms inactivated die from asphyxia at birth [17]. In
Dp1/+6Dp1/+ offspring, the ratio of the genotype of Dp1/
+6Dp1/+ offspring differed significantly from the expected 1:2:1
(homozygous:heterozygous:wild type) ratio (0.01,P,0.05, chi-
square test), indicating an effect on viability.
Reduction of M receptors in the sphincter pupillae causes
the dilated pupil phenotype
To analyze the defect that caused the dilated pupil phenotype
and cure the abnormal phenotype, we used drugs to clinically
constrict or enlarge the pupils. A 1% pilocarpine solution (a
nonselective muscarinic cholinergic receptor agonist) was first
applied as drops in the eyes of mice with severe and partially
dilated pupil phenotypes, but it did not alter pupil size in mice with
either phenotype (full or partial dilation of the pupil). In contrast,
administration of a 1% atropine solution, a muscarinic cholinergic
receptor antagonist which can compete for AchR with Ach (we
considered the drug effect to be a blocking of the AchR), resulted
in the further loosening of the sphincter pupillae, which led to
complete mydriasis in partially dilated pupil mice. Taken together,
these results suggest that the number of muscarinic receptors
might be decreased in the iris constrictor muscles of mutant mice,
while the number of muscarinic receptors in partially dilated pupil
mice is higher than in mice with a severely dilated pupil
phenotype. The contractile extent of the sphincter corresponds
to the amount of Ach and the number of AchR. Due to the
decrease in AchR in partially dilated pupil mice, an excess of Ach
with a limited number of AchR cannot lead to complete muscle
contraction. In addition to pilocarpine, we used drops of a 1%
neostigmine solution (a cholinesterase inhibitor) or both solutions
together in dilated pupil mice, but both drugs failed to constrict the
mutant pupils (full or partial dilation of the pupil). After
intraperitoneal administration of pilocarpine or neostigmine in
Dp1 mice, severe salivation and mild lachrimation were observed,
suggesting that AchRs in the glands of Dp1 mice were not (or only
slightly) affected (data not shown).
M receptors comprise five distinct subtypes (M1–M5). M3 is
known to play a dominant role in eliciting smooth muscles
contraction, and M32/2 mice showing a partially dilated pupil
phenotype have been reported [18,19]. To further validate the
reduction of M receptors in the sphincter papillae of Dp1 mice, we
performed immunohistochemistry tests using an anti-M3 antibody
and found a significant reduction of M3 receptors in the sphincter
pupillae of Dp1/Dp1 mice (Figure 6).
Discussion
We report a novel dilated pupil phenotype mouse (Dp1), which
was obtained by ENU mutagenesis. The abnormal phenotype is
Figure 2. Genetic mapping places the mutant in the region between markers rs32829041 and D8Mit4. Primary markers used to refine
the map position are listed on the left from the centromere (top), and the number of animals in each genotypic class is shown at the bottom. 1
a and
1
b: mice with unilateral and partially dilated pupil phenotypes. The others are mice with a severe bilaterally dilated pupil phenotype.
doi:10.1371/journal.pone.0025176.g002
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exon. Quantitative and sequence analysis of Nrg1 revealed that the
mutation affected, but did not abolish, the splicing of EGFb-type
Nrg1 mRNA and produced several altered transcripts. These types
of protein isoforms were expected, and the results show that, in the
mutant, there was a decrease in, but not an elimination of, EGFb-
type Nrg1 isoforms. This was partially compensated for by the
increased expression of alpha forms or inactive proteins. NRG1s
with b-type EGF-like domain isoforms are 10–100 times more
potent than NRG1s with an a-type EGF-like domain [8]. The
results indicated that the mutation results in a hypomorphic allele.
Although pan-NRG1, Ig-NRG1 and CRD-NRG1 KO mice have
existed for many years, the relationship between Nrg1 mutation
and the dilated pupil phenotype had not been reported until now.
This study is the first to report an Nrg1 mutation associated with
the dilated pupil phenotype. The Nrg1 gene has more than 20
exons and gives rise to at least 15 different isoforms of the protein.
In this paper, we also report new transcripts that had not been
reported previously.
Pupil size is controlled by two different sets of involuntary
muscles, the sphincter pupillae and the dilator papillae, which act
in opposition to cause miosis (constriction) or mydriasis (dilation) of
the pupil in response to different levels of light or during focal
adjustment [20]. The sphincter muscle is innervated by the
parasympathetic nervous system, which acts by releasing acetyl-
choline which acts on M receptors [21]. The dilator papillae are
innervated by the sympathetic system, which acts by releasing
noradrenaline which acts on a1-receptors [22]. Pharmacological
and immunohistochemical tests showed a reduction in M receptors
in the sphincter pupillae of Dp1 mice, which is a major contributor
to the dilated pupil phenotype. This is the first report of an Nrg1
mutation being associated with the reduction of M receptors.
The role of NRG1 in mediating the nerve-dependent accumula-
tion of AchRs in the postsynaptic membrane of nerve-muscle
Figure 3. Nrg1 gene structure and mutation identification. (A) Mouse Nrg1 gene structure. Exons are represented as vertical bars and are
numbered as per Steinthorsdottir et al. [2004], Paul et al. [2006] and Chen et al. [2008]. In the absence of an agreed or definitive exon numbering
system for NRG1, exons are labeled as described by Steinthorsdottir et al. [2004] with the number denoting their length in nucleotides. The 59 exons,
which define the ‘‘types’’ of NRG1, are in black with the corresponding Roman numeral above (including three additional 59 exons found in humans
that encode type IV, V, and VI). In mice, exon E171 may encode isoforms with a ‘‘3’’ stalk (see Figure 4 and 5). (B) Sequence analysis of the Nrg1 gene
product obtained using PCR of genomic DNA discovered a G to A transition mutation in Dp1/Dp1 homozygous mice compared to wild-type B6 mice.
(C) The mutation located in the 59 splice donor site that flanks exon E59 encoding the EGFb domain. (D) Electrophoresis results using primers specific
for CRD-Nrg1 and Ig-Nrg1 from homozygous Dp1 and wild-type B6 mice, respectively. M, molecular weight markers. GAPDH, glyceraldehyde-3-
phosphate dehydrogenase. (E) Quantitative analysis of Nrg1 mRNA levels in band b by densitometry. Ratio: ratio of volume (intensity) of respective
Nrg1 and GAPDH mRNA RT-PCR product. **p,0.01 vs. respective Dp1/Dp1 group (n=4).
doi:10.1371/journal.pone.0025176.g003
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nicotinic (N) and M receptors. AchRs in the sphincter pupillae belong
to the latter. As a result of the reduction of N receptors in the
postsynaptic membrane, mice that are heterozygous for the deletion
of neuregulin isoforms containing an immunoglobulin-like domain
are myasthenic [23,24]. In Dp1 mice, both Ig-Nrg1 and CRD-Nrg1
EGFb-type isoforms are affected. Although myasthenia of skeletal
muscle due to inactivation of Ig-NRG1 isoforms in mice has been
previously reported, we cannot confirm the exact mutation where
NRG1 isoforms are responsible for the abnormal phenotype caused
by the reduction of M receptors in smooth muscles.
As a whole, the phenotype of affected heterozygous mice is
milder than that of homozygous mice, and the mutation can be
described as a semi-dominant mutation with respect to the
expressivity of the mutant phenotype. However, the Dp1 dilated
pupil phenotype is inherited with very low penetrance in
heterozygous mice and with complete penetrance in homozygous
mice. Knowledge of this interesting inheritance pattern will be
helpful in establishing additional mutant mice lines and models of
human genetic disease and can be applied to other organisms.
Having a knockout with a severe phenotype (complete loss-of-
function) is both advantageous and disadvantageous; it is an
advantage because it provides reassurance that the gene of interest
has an essential role, and it is a disadvantage because death or
early developmental disruptions in the mutants preclude the
analysis of later developmental events. The homozygous lethality
of pan-NRG1, Ig-NRG1 and CRD-NRG1 KO mice hampers
further knowledge of Nrg1 function. Dp1 is a partial loss-of-function
mouse model and approximately 50% of Dp1 homozygous mice
are viable, which makes these mice a valuable resource for further
clarifying the biological functions of Nrg1.
Conclusion
We have identified a mutant mouse, Dp1, with a dilated pupil
phenotype. The abnormal phenotype is caused by a base
substitution flanking the exon encoding for the EGFb domain,
which affects the splicing of EGFb-type Nrg1 mRNA. Protein
isoforms are expected, and the results show a decrease in higher
affinity EGFb-type Nrg1 isoforms. These are partially compen-
sated for by increased expression of the lower affinity alpha forms
or inactive proteins, suggesting that Dp1 is a partial loss-of-function
mouse model and that the mutation results in a hypomorphic
allele. Further tests showed a reduction of M receptors in the iris
constrictor muscles of Dp1 mice, which is a major cause of the
dilated pupil phenotype. The Dp1 dilated pupil phenotype is
inherited with very low penetrance in heterozygous mice and with
complete penetrance in homozygous mice. This interesting
inheritance pattern could be helpful in establishing more mutant
mouse lines and models of human genetic diseases and can be
applied to other organisms. Dp1 mice are a valuable resource for
further clarifying the biological functions of Nrg1.
Materials and Methods
Ethics statement
C57BL/6J (B6), C3He/J (C3H) and DBA/2J (D2) mice were
obtained from the Shanghai Laboratory Animal Center (Shang-
hai, China). This study was conducted in strict accordance with
the recommendations given in the Guide for the Care and Use of
Laboratory Animals of the National Research Council. The
animal care and use committee of Yangzhou University approved
all experiments and procedures conducted on the animals
(approval ID: SYXK (Su) 2007-0005).
Figure 4. Transcripts of CRD-Nrg1 and the expected protein isoforms in wild-type and Dp1/Dp1 homozygous mice. (A) RT-PCR amplified
region of CRD-Nrg1 transcripts. The primers used for RT-PCR are indicated; the arrow indicates the approximate primer position within the exon. (B)
Transcripts of CRD-Nrg1 produced by wild-type mice. (C) Transcripts of CRD-Nrg1 produced by Dp1/Dp1 homozygous mice. In band a, one transcript
contains a new exon, E104 (which is expected to produce a truncated protein without the EGFc, EGFb, and EGFa domains), and another transcript
(accounting for 6/7 of the clones) transcribes through exon E59 into the adjacent 112 bp sequence (which is expected to produce CRD-b3 type
isoforms). In band b, one transcript (accounting for 4/7 of the clones) bypasses the mutated splice donor site by splicing over exon E59 (which is
expected to produce CRD-a2 type isoforms).
doi:10.1371/journal.pone.0025176.g004
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Genomic DNA was isolated from mouse tail tips by proteinase
K digestion, phenol chloroform extraction, and ethanol precipi-
tation. Total RNA was extracted from the brains of Dp1 and wild-
type mice using TRIzol reagent (Invitrogen, Carlsbad, CA).
Genetic mapping and mutation screening
As a first step for assigning a chromosomal location to the
mutant, we crossed Dp1 animals on the B6 genetic background
to C3He/J (C3H) or DBA/2J (D2) mice. F1 offspring were then
backcrossed to wild type (+/+) B6 animals to obtain BCB or
BDB N2 mice. DNA from N2 offspring exhibiting dilated pupils
was used to scan the genomic sequence. Due to a very low
penetrance in this kind of mating strategy, after mapping the
mutation to a chromosome, we tried to outcross Dp1 animals on
the B6 genetic background to C3H mice or D2 to obtain F1 mice
a n dt h e nc r o s s b r e e dt h eF 1m i c et oo b t a i na nF 2 .D N Ao fF 2
offspring exhibiting dilated pupils was used to refine the mutant
Table 1. Genetic model testing.
Genotype. Parents Dp/+6Dp/+ Dp/Dp6Dp/+ Dp/Dp6+/+ Dp/Dp6Dp/Dp
Total no. of offspring n=108 n=11 n=41 n=132
Genotype of offspring Dp/Dp Dp/++ /+ Dp/Dp Dp/+ Dp/+ Dp/Dp
No. of affected offspring 16 3 0 4 0 2 132
Total no. of offspring of each genotype 16 63 29 4 7 41 132
In the test, all affected heterozygous offspring have a unilaterally and partially dilated pupil phenotype, but the size of the pupil varies with each individual.
Of the 152 homozygous offspring, 148 have a severe bilaterally dilated pupil phenotype, 3 show a bilateral dilated pupil phenotype with one completely and one
partially dilated pupil, and 1 has a severe unilaterally dilated pupil phenotype.
doi:10.1371/journal.pone.0025176.t001
Figure 5. Transcripts of Ig-Nrg1 and the expected protein isoforms produced by wild-type and Dp1/Dp1 homozygous mice. (A) RT-PCR
amplified region of Ig-Nrg1 transcripts. The primers used for RT-PCR are indicated; the arrow indicates the approximate primer position within the
exon. (B) Transcripts of Ig-Nrg1 produced by wild-type mice. (C) Transcripts of Ig-Nrg1 produced by Dp1/Dp1 homozygous mice. In band a, three kinds
of transcripts (accounting for 11/12 of the clones) bypass the mutated splice donor site by either splicing over exon E59, activating a cryptic splice
site, or transcribing through exon E59 into the adjacent 112 bp sequence (one transcript, accounting for 6/12 of the clones, is expected to produce
Ig-a2 type isoforms). In band b, two kinds of transcripts (accounting for 4/6 of the clones) bypass the mutated splice donor site by splicing over exon
E59 (one transcript, accounting for 1/6 of the clones, is expected to produce Ig-a2 type isoforms and the other transcript, accounting for 3/6 of the
clones, is expected to produce isoforms without the EGFb and EGFa domains).
doi:10.1371/journal.pone.0025176.g005
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sequenced.
Reverse transcription–polymerase chain reaction
The cDNA was synthesized using the RevertAid First Strand
cDNA SynthesisKit (Fermentas, EU)with Olig(dT)18 primers.RT-
PCR for CRD-Nrg1 was performed with the following primers: F1
59-CCAAGTCAGGAACTCAGCCACAAA-39 and R1 59-CGC-
TATGTTCACCATGTTGTTTCGT-39. RT-PCR for Ig-Nrg1
was conducted with the primers F2 59-CGTAGGAATAAACCAC-
AAAACGTC-39 and R2 59-GAGCCGATCATGAAGCTTCT-
GCCG-39. RT-PCR control reactions specific for the housekeeping
gene Gapdh were preformed with the following primers: 59-CTT-
TGGCATTGTGGAAGGG-39 and 59- CCTCTCTTGCTGCA-
GTGTC-39.
Genotyping of mice
The point mutation in Dp1 abolished a TaiI restriction site
presentinthe wild-typesequence.A360-bpfragmentencompassing
the point mutation was amplified from genomic DNA using a
forward primer, 59-TCTGTCAGTGACACTACAGGAGCTC-
39, and reverse primer, 59-GTAACTCAGAGCCGACTAGT-
CACA-39. Digestion of the PCR product with Tai I was predicted
togiveDNAfragments ofthefollowing sizes:+/+ mice- three bands
of 200 bp, 137 bp and 23 bp (the 360 bp PCR product of +/+
micecontainstwoTaiIrestrictionsites);heterozygotes-fourbandsof
223 bp, 200 bp, 137 bp and 23 bp; and Dp1/Dp1 mice - two bands
of 223 bp and 137 bp. A 4% gel electrophoresis revealed DNA
bands with sizes consistent with this prediction.
Immunohistochemistry
Eyeballs were fixed in a 4% paraformaldehyde solution in PBS,
dehydrated, wax-embedded and sectioned at 6 mm. A rabbit
polyclonal antibody against Chrm3 (Bioss, Beijing, China) was
used to label Chrm3. Immunohistochemical analyses was
performed using the Boster (Wuhang, China) reagents according
to the manufacturer’s instructions. The sections were visualized by
incubation with 3-amino-9-ethylcarbazole (AEC) and were
counterstained with Mayer’s hematoxylin.
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